Hardman Johnston Global Advisors LLC Abb Vie Inc. Transaction History

Hardman Johnston Global Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 03, 2019	SELL	$77.14 - $90.79 $3.68 Million - $4.34 Million	-47,758 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$77.85 - $96.01 $136,237 - $168,017	-1,750 Reduced 3.53%	47,758 $4.4 Million
Q1 2018 Apr 30, 2018	SELL	$92.01 - $123.21 $9,201 - $12,321	-100 Reduced 0.2%	49,508 $4.69 Million
Q4 2017 Jan 26, 2018	SELL	$89.56 - $98.21 $71,648 - $78,568	-800 Reduced 1.59%	49,608 $4.8 Million
Q3 2017 Oct 30, 2017	SELL	$69.85 - $89.22 $43,027 - $54,959	-616 Reduced 1.21%	50,408 $4.48 Million
Q2 2017 Aug 14, 2017	BUY	N/A	51,024	51,024 $3.7 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Hardman Johnston Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hardman Johnston Global Advisors LLC with notifications on news.